Get the app!
Back to Trades

JORDEN DAVID EMERSON

CEO/CFODirectorCIK 0001313516

Total Volume

$1.3M

6 filings

Purchases

$0

0 buy txns

Sales

$300.0K

1 sell txns

Net Activity

-$300.0K

net sold

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
6
Buy transactions
0
Sell transactions
1
Companies
1
Active
2025–2026

JORDEN DAVID EMERSON, CEO/CFO, Director, has filed 6 SEC reports (2025–2026), all concentrated in Nuo Therapeutics, Inc. (AURX), totaling $1.3M in disclosed volume. Weighing $0 bought versus $300.0K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.

Associated Companies

Nuo Therapeutics, Inc. (AURX)

6 filings

$1.3M

Trading History

6 loaded
Aug 28AURX
Nuo Therapeutics, Inc.
JORDEN DAVID EMERSONCEO/CFO, DirectorGrant$9.5K
Jul 2AURX
Nuo Therapeutics, Inc.
JORDEN DAVID EMERSONCEO/CFO, DirectorExercise$613.8K
Jun 5AURX
Nuo Therapeutics, Inc.
JORDEN DAVID EMERSONCEO/CFO, DirectorGrant$14.5K
Jan 5AURX
Nuo Therapeutics, Inc.
JORDEN DAVID EMERSONCEO/CFO, DirectorExercise$150.0K
Dec 3AURX
Nuo Therapeutics, Inc.
JORDEN DAVID EMERSONCEO/CFO, DirectorSell$300.0K
Aug 4AURX
Nuo Therapeutics, Inc.
JORDEN DAVID EMERSONCEO/CFO, DirectorExercise$191.3K

6 filings